Advertise on podcast: Parkinson's Disease Podcasts by No Silver Bullet

In this special annual review, we are joined by Dr Simon Stott, Director of Research at Cure Parkinson's. Simon shares his key Parkinson’s research takeaways from 2025 and discusses the breakthrough results he is looking for in 2026. If you find our webinars helpful, please Subscribe to NoSilverBullet4PD. By following us, you are helping our community become more visible on the internet. This allows us to reach more people worldwide living with Parkinson’s, giving them the opportunity to access vital expertise and a holistic strategy for managing their condition. 00:00 – Introduction 05:15 – Dr Simon Stott: Cure Parkinson’s Research Overview 15:30 – 2025 Research Takeaways: Trials and Triumphs 35:45 – Looking Ahead: What to expect in 2026 50:10 – Audience Q&A 01:05:00 – Closing Remarks & Next Webinar Announcement Websites: https://cureparkinsons.org.uk/ https://nosilverbullet4pd.com https://pdbuddy.app/ Follow us on Instagram: @nosilverbullet4pd This session is for information and education purposes only. If you are seeking medical advice, please consult a medical professional. Full disclaimer details can be found here: https://nosilverbullet4pd.com/disclamer-.html

Is it possible to repair the brain in Parkinson's disease? In this special webinar, we are joined by Professor Roger Barker from the University of Cambridge to answer that very question. Professor Barker is a global leader in cell-based therapies and a Principal Investigator at the Cambridge Stem Cell Institute. In this talk, he breaks down the science of replacing lost dopamine cells, the history of fetal tissue transplants, and the exciting new era of stem cell trials. He discusses the potential for a "one-off" treatment that could restore dopamine levels to normal, the challenges of past trials, and what the future holds for people living with Parkinson's today. About the Speaker: Professor Roger Barker is a Professor of Clinical Neuroscience and Consultant Neurologist at Addenbrooke’s Hospital, Cambridge. He leads the Stem-PD clinical trial and is a central figure in the global G-Force PD consortium, working to bring stem cell therapies to the clinic. About NoSilverBullet4PD: We are a Parkinson's support group. We believe that while there is no single "silver bullet," there is plenty of "silver buckshot"—tools and knowledge to help us live better. ⚠️ MEDICAL DISCLAIMER: This content is for informational and educational purposes only and is not intended as a substitute for professional medical advice. Always consult your physician or specialist regarding your Parkinson's treatment and care. JOIN OUR COMMUNITY: Want more expert insights? Register for our webinars and updates at https://nosilverbullet4pd.com/

Join Beatrice from PD Buddy and Curaleaf UK experts Dr Mark Weatherall and Dr Simon Erridge for a clear and practical discussion on medical cannabis in Parkinson’s care. Interest in medical cannabis is growing among people with Parkinson’s, but so is confusion. Many people with Parkinson's are unsure about what cannabis can help with, how to access it legally, or why some products work while others don’t.   To bring clarity, Beatrice, the founder of the PD Buddy app, invited two specialists from Curaleaf UK for a straightforward discussion focused on real-life concerns: Which symptoms might cannabis help? What’s the difference between medical and recreational products? How do you know what dose or format is right? What are the risks? How does someone begin the process of getting a prescription? Throughout the session, the conversation stays practical and grounded in everyday challenges faced by people with Parkinson’s — sleep, pain, stiffness, and overall quality of life. The goal is not to promote cannabis, but to provide reliable information so people can make safer, better-informed choices. Medical cannabis is regulated very differently around the world. What is allowed, and how it is prescribed, varies widely. Nothing we discuss today should be taken as medical or legal advice, and we encourage everyone to check the rules in their own country, state or region.

In this interview, Beatrice Zatorska, Founder of PD Buddy app sits down with Scott McLeod, co-founder of StrydAR, to explore their groundbreaking Parkinson’s Walking Glasses. These glasses use Visual Cueing technology, inspired by fighter pilot helmets, to help people with Parkinson’s overcome common mobility challenges such as freezing of gait, slowness, and balance issues. We cover everything from how the holographic cue works, what symptoms it targets, and how quickly people notice improvements in walking, posture, and confidence. Scott explains when and how to use the glasses, whether prescription lenses are needed, and what the cost and trial options look like. The conversation also dives into personal stories from users, unexpected benefits like improved confidence and mental well-being, and what’s next for StrydAR — including upcoming trials and new features. If you or someone you know is living with Parkinson’s and struggling with walking or freezing, this interview offers practical insight into an innovative tool designed to make daily life safer and more independent. Please note that this session is for informational and educational purposes only. If you are seeking medical advice, please consult a qualified healthcare professional. 👉 Learn more about StrydAR: https://www.parkinsonswalkingglasses.... 👉 Download PD Buddy App for free: https://pdbuddy.app/

We were delighted to host Dr Briana De Miranda on the topic of "How the environment affects Parkinson's Disease and what you can do about it." As Parkinson's diagnoses continue to rise worldwide, increasing attention is being given to the role of environmental factors in the disease's onset and progression, and to the practical steps we can take to better protect ourselves from these risks. Briana De Miranda, Ph.D., is a Neurotoxicologist and Associate Professor of Neurology in the Killion Center for Neurodegeneration at the University of Alabama at Birmingham. Her research focuses on environmental risks for neurodegenerative diseases, integrating expertise in toxicology, pharmacology, and neuroscience. Her interdisciplinary research is aimed at understanding how neurodegeneration is caused by environmental exposures, and finding ways to treat or prevent neurologic disorders caused by toxic risk factors. More about the speaker:- https://scholars.uab.edu/16563-briana-de-miranda https://www.parkinson.org/living-with-parkinsons/stories/briana-de-miranda https://www.linkedin.com/in/briana-de-miranda-3196a231 https://www.sciencedirect.com/science/article/pii/S0969996121000619

We were delighted to host Carl Beech, the creator of the Beech Band, a new wearable device to manage Parkinson’s symptoms. Carl was 51 when he was diagnosed with Young-Onset Parkinson’s.  He began to experience slurring and a rapidly worsening stammer. Faced with the loss of speech, he nearly gave up hope. But then, while experimenting with a therapeutic tapping technique, he had a personal breakthrough – rhythmic tapping allowed him to regulate his speech and relieve his stammer. This led to an idea: what if this could be turned into a wearable device that could help many more people? Today, Carl will be sharing his experience with the Beech Band. After 13 months of wearing the device Carl has experienced remarkable changes to his symptoms. Since its release in July over 15,000 have been sold and there have been very positive reactions from user. Whilst this story is inspiring and hopeful,  it’s important to remember that Parkinson’s is complex, and no single approach works for everyone and that the positive responses are anecdotal. The Beech Band is a wellness device, not a medical treatment, so please speak with your medical team if you have any concerns about using the device or are considering any changes to your medication. More information on the device can be found here:- https://www.beechband.com/ https://www.facebook.com/p/BeechBand-61563836532593/ https://www.instagram.com/beechband/?hl=en https://www.tiktok.com/@beechband

We are delighted to once again host Dr. Matthew Phillips, who presented on: "Optimising Parkinson’s: Essential Therapies". Matt joined us first back in Feb 2023 when he presented "Intermittent Fasting & Keto & Diet Strategies" which has had over 100,000 views since and can still be watched on our YouTube channel  https://www.youtube.com/@nosilverbullet4pd998/videos In this new session, Dr Phillips will offer a broader framework to help people with Parkinson’s navigate and combine various therapeutic options, going well beyond the fasting and ketogenic protocols explored in his previous talks.

We are delighted to share this update from Dr Sackner-Bernstein, following his previous webinar titled “Why I Am Optimistic That We Might Have a Silver Bullet for PD.” In this new update, he builds on the key ideas from his earlier presentation and shares the latest developments that continue to fuel his optimism. Dr Sackner-Bernstein is the author of a 2021 peer-reviewed study published in The Journal of Parkinson’s Disease, where he proposed that the standard treatment approach to Parkinson’s might actually be the opposite of what is most effective. We had the pleasure of hosting him last year, and we’re excited to hear his latest insights. If you’d like a deeper dive into this topic, you can find our full conversation from June last year on our YouTube channel. Please note: This content is for informational and educational purposes only. For medical advice, please consult your healthcare provider. Thank you, The No Silver Bullet Team

We are delighted to share with you our latest recording  featuring Dr. Alfonso Fasano, a world-renowned neurologist and researcher, presenting “New Allies Against Parkinson’s: Adaptive DBS & Subcutaneous Foslevodopa”. 🌟 What to Expect This webinar will explore two groundbreaking treatments that are changing the landscape of Parkinson’s care: Adaptive Deep Brain Stimulation (aDBS): Learn how this technology personalizes stimulation in real time to better manage symptoms and reduce side effects. Subcutaneous Foslevodopa: Discover how this new delivery method could offer smoother and more continuous relief from motor fluctuations, potentially replacing traditional oral medications. 👨‍⚕️ About the Speaker Dr. Alfonso Fasano is a neurologist specializing in movement disorders, with roles in both Italy and Canada. He is Professor of Neurology at Humanitas University and Head of Neurology at Humanitas Research Hospital in Milan. He also holds a professorship in the Department of Medicine (Division of Neurology) at the University of Toronto and is a staff neurologist at Toronto Western Hospital and the Hospital for Sick Children. Dr. Fasano’s main research interests include using advanced technologies—such as infusion pumps and brain stimulation—to treat Parkinson’s disease, tremor, and walking disorders. He has published over 500 scientific articles, and serves on the editorial boards of leading journals in neurology and movement disorders. He is also actively involved in clinical trials and international research groups.

"Women’s Health & Parkinson’s", a special webinar in collaboration with the PD Buddy App in now available as a Podcast This session explores the connection between menopause, hormones, and Parkinson’s, providing valuable insights and practical strategies to help you navigate these changes. Led by Dr. Tanya Denne, ND, a naturopathic doctor and researcher, the webinar covers key topics such as hormone replacement therapy (HRT), fatigue, nutrition, gut health, and more. Through evidence-based approaches and real-world case studies, Dr. Denne bridges the gap between neurology, primary care, and holistic wellness—offering tangible takeaways to help you optimise your health and care plan. This event is brought to you in partnership with the PD Buddy App (https://pdbuddy.app/ a free digital tool designed to support people with Parkinson’s and their caregivers. PD Buddy helps you organise routines, track symptoms, and access expert resources, making it easier to manage day-to-day life with Parkinson’s. If you have questions following this webinar, please do not hesitate to contact Dr Denne on: DoctorDenne.com [email protected]

We were delighted to welcome Dr. Wayne Markman, CEO of SYMBYX, for an insightful update on the latest clinical trials using light therapy to ease Parkinson’s symptoms. SYMBYX stands out for its strong focus on evidence-based innovation, investing significantly in medical research to better understand and validate the role of light therapy in Parkinson’s care. For a deeper dive into the science and potential benefits, check out our earlier interview with Dr. Markman from November 2023 on our YouTube channel. This session is intended for informational and educational purposes only. If you're seeking medical advice, please consult a healthcare professional.

Thank you to Prof Malu Tansey who joined us to share her expertise on the topic of "Inflammation and Parkinson's and what we can do about it" This presentation was excellent and we encourage you to watch it and the Q&A that followed as you will certainly come away with a better understanding of this complicated topic. About the Speaker:- Malú Gámez Tansey, Ph.D., is a Professor of Neurology and the James Caplin Chair in Alzheimer’s Disease at Indiana University School of Medicine and Director of Neuroimmunology Research Group & Executive Associate Director of Education at the Stark Neuroscience Research Institute. Her lab focuses on the role of inflammation and immune system responses in brain health and neurodegenerative disease, with particular focus on central-peripheral neuroimmune crosstalk and the gut-brain axis, with the long-term goal of developing better therapies to prevent and/or delay these diseases. Dr. Tansey obtained her B.S/M.S in Biological Sciences from Stanford University and her Ph.D. in Cell Regulation from UT Southwestern, followed by post-doctoral work in neuroscience at Washington University.  She returned to academia as an Assistant Professor of Physiology at UT Southwestern in 2002 and was recruited to Emory University School of Medicine as a tenured Associate Professor in 2009. After 10 years at Emory and rising to the rank of Full Professor, in 2019, she was recruited to the Department of Neuroscience in the College of Medicine at the University of Florida as the Fixel Chair in Neuroscience and Neurology and Director of the Centre for Translational Research in Neurodegenerative Disease. She also served on the executive committees for the McKnight Brain Institute and the Fixel Institute for Neurological Diseases.

We recently hosted two webinars on Mucuna pruriens, a tropical legume rich in levodopa. The first, with Dr. Roberto Cilia, focused on the use of Mucuna in low-income countries where levodopa is often unavailable or unaffordable. The second, with Dr. Rafael Maldonado, took a broader perspective. Due to continued interest and questions on mucuna, we organised today’s session with Dr. Tanya Denne. Since 2010, Dr. Denne has researched Mucuna for its potential in treating Parkinson's.  Having been mentored by Dr. Laurie Mischley, she chose her Naturopathic Medical School with a focus on serving the Parkinson's community. Dr. Denne treats the whole person with a personalized, holistic approach and specializes in optimizing care plans and addressing treatment gaps. Driven by her passion for public health, she joined Dr. Roberto Cilia in Ghana in February to help tackle Parkinson's care in countries where Mucuna is sometimes all they have.  This session is intended for informational and educational purposes only. If you're seeking medical advice, please consult a healthcare professional.  For those who are new to us, “No Silver Bullet” is managed by Mark Limebear and myself, with the goal of sharing valuable Parkinson's expertise. Our mission is to empower you with knowledge and motivation to make informed choices about adapting your lifestyle to manage your symptoms and slow disease progression. We also share recordings of our webinars on YouTube and Spotify. You can find the details on our website: nosilverbullet4pd.com. If you have questions following this webinar, please do not hesitate to contact Dr Denne on: DoctorDenne.com [email protected]

We are delighted to share with you our latest recording "A new Parkinson's test- hope or hype?" a webinar on the alpha-synuclein seed amplification assay (αSyn-SAA), presented by the M J Fox Foundation as a significant breakthrough in the search for a Parkinson's biomarker. With the growing interest surrounding αSyn-SAA, it’s crucial for patients and their families to understand both its potential benefits and limitations. About the Speaker:- Dr. Alberto Espay is Professor and Endowed Chair of the James and Joan Gardner Center for Parkinson's Disease at the University of Cincinnati. He has published over 300 research articles and 8 books, including Common Movement Disorders Pitfalls, which received the Highly Commended BMA Medical Book Award in 2013 and Brain Fables, the Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer them, co-authored with Parkinson's patient and advocate Benjamin Stecher, selected by the Association of American Publishers for the PROSE Award honouring the best scholarly work in Neuroscience published in 2020. With colleagues at the University of Cincinnati, he recently launched the first biomarker study of aging (CCBPstudy.com), designed to match people with neurodegenerative disorders to available therapies from which they are most biologically suitable to benefit, regardless of their clinical diagnoses.

Join us for a deep dive into the sleep challenges faced by Parkinson's patients and the potential solutions with Prof S Overeem! Prof. Overeem is a distinguished clinical somnologist and sleep researcher renowned for his expertise in sleep medicine (he was recommended to us by Prof. Bas Bloem). He practices at the Center for Sleep Medicine Kempenhaeghe in the Netherlands, a leading institution dedicated to diagnosing and treating sleep disorders. His clinical focus encompasses a wide range of somnological conditions, with particular interests in narcolepsy, hypersomnias, parasomnias, and sleep disorders associated with Parkinson’s disease. In 2015, he became a senior researcher at Eindhoven University of Technology where he established a pioneering research program aimed at developing innovative diagnostic methods for sleep and its related disorders. He was appointed full professor in June 2017, solidifying his role as a leader in the field. Outside of his professional pursuits, Prof. Overeem enjoys exploring the depths of the ocean and the expanses of the sky, indulging his passions as an avid scuba diver and private pilot.